The in vitro data confirmed that our BDNF AntagoNAT constructs encapsulated in liposomes are capable of inducing both BDNF transcription and translation in BDNF NAT-expressing rat schwannoma cells at 48 h. The gene discussed is BDNF; the disease is schwannoma.